Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol

Clicks: 542
ID: 116962
2011
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #3 of 28 articles by views in Blood

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Hemophagocytic lymphohistiocytosis (HLH) used to have a dismal prognosis. We report the final results of HLH-94, the largest prospective diagnostic/therapeutic HLH study so far. The treatment includes immunosuppressive and cytotoxic therapy aiming at clinical remission, followed by HSCT in patients …
Reference Key
h2011bloodchemoimmunotherapy Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Trottestam H, Horne A, Aricò M, Egeler RM, Filipovich AH, Gadner H, Imashuku S, Ladisch S, Webb D, Janka G, Henter JI
Are you one of these authors? Claim your profile
Journal Blood
Year 2011
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/21900192
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male adolescent Child Infant Immunosuppressive Agents / administration & dosage* Immunosuppressive Agents / adverse effects newborn preschool Clinical Trial follow-up studies Survival Analysis time factors drug combinations combined modality therapy lymphohistiocytosis hemophagocytic / diagnosis maintenance chemotherapy hemophagocytic / drug therapy* immunotherapy / methods pmid:21900192 pmc3208276 doi:10.1182/blood-2011-06-356261 helena trottestam annacarin horne histiocyte society clinical protocols cytotoxins / administration & dosage* cytotoxins / adverse effects hematopoietic stem cell transplantation immunotherapy / adverse effects hemophagocytic / mortality hemophagocytic / therapy

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.